Cadrenal Therapeutics, Inc. — All Filings
222 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-25-091109 | Sep 24, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-087461 | Sep 15, 2025 | Sep 12, 2025 |
| 4 | — | 0001213900-25-082821 | Aug 29, 2025 | Aug 27, 2025 |
| 4 | — | 0001213900-25-082819 | Aug 29, 2025 | Aug 27, 2025 |
| 144 | — | 0001950047-25-006505 | Aug 28, 2025 | — |
| 144 | — | 0002007317-25-000998 | Aug 28, 2025 | — |
| 144 | — | 0001950047-25-006446 | Aug 27, 2025 | — |
| 144 | — | 0002007317-25-000971 | Aug 27, 2025 | — |
| 144/A | — | 0002007317-25-000978 | Aug 27, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-073885 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-074355 | Aug 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-071764 | Aug 5, 2025 | — |
| ARS | FORM ARS | 0001213900-25-069619 | Jul 31, 2025 | Dec 31, 2024 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-069615 | Jul 31, 2025 | — |
| DEF 14A | PROXY STATEMENT | 0001213900-25-069612 | Jul 31, 2025 | Sep 24, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-065710 | Jul 18, 2025 | Jul 15, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-040788 | May 8, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-041049 | May 8, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-032732 | Apr 17, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-032730 | Apr 17, 2025 | — |
| 4/A | OWNERSHIP DOCUMENT | 0001013762-25-001779 | Mar 24, 2025 | Jan 23, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-023762 | Mar 13, 2025 | — |
| 10-K | ANNUAL REPORT | 0001213900-25-023759 | Mar 13, 2025 | Dec 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-25-019747 | Mar 4, 2025 | Mar 3, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-012684 | Feb 12, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-011315 | Feb 7, 2025 | Feb 4, 2025 |
| 4 | — | 0001213900-25-010973 | Feb 6, 2025 | Feb 5, 2025 |
| 3 | — | 0001213900-25-010970 | Feb 6, 2025 | Feb 5, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-009518 | Feb 3, 2025 | — |
| SCHEDULE 13D | — | 0001213900-25-007997 | Jan 29, 2025 | — |
| 4 | — | 0001213900-25-006639 | Jan 24, 2025 | Jan 23, 2025 |
| 4 | — | 0001213900-25-006640 | Jan 24, 2025 | Jan 23, 2025 |
| 4 | — | 0001213900-25-006638 | Jan 24, 2025 | Jan 23, 2025 |
| 4 | — | 0001213900-25-006628 | Jan 24, 2025 | Jan 23, 2025 |
| 4 | — | 0001213900-25-006630 | Jan 24, 2025 | Jan 23, 2025 |
| 4 | — | 0001213900-25-006633 | Jan 24, 2025 | Jan 23, 2025 |
| 4 | — | 0001213900-25-006635 | Jan 24, 2025 | Jan 23, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-003853 | Jan 15, 2025 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-24-111956 | Dec 23, 2024 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-111291 | Dec 20, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-24-102233 | Nov 25, 2024 | — |
| EFFECT | — | 9999999995-24-003563 | Nov 22, 2024 | — |
| CORRESP | — | 0001213900-24-100954 | Nov 21, 2024 | — |
| UPLOAD | — | 0000000000-24-012892 | Nov 20, 2024 | — |
| SC 13G/A | — | 0001172661-24-005145 | Nov 14, 2024 | — |
| D | — | 0001213900-24-097866 | Nov 14, 2024 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-24-098411 | Nov 14, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-095195 | Nov 7, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-095393 | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-094155 | Nov 4, 2024 | Nov 1, 2024 |